Sevelamer improves hepatic steatosis and modulates inflammation in a Western Diet mouse model of non-alcoholic fatty liver disease (NAFLD)

被引：0
|
作者：
McGettigan, Brett [1 ]
McMahan, Rachel [1 ]
Porsche, Cara [1 ]
Orlicky, David J. [1 ]
Wang, Xiaoxin [1 ]
Luo, Yuhuan [1 ]
Levi, Moshe [1 ]
Rosen, Hugo R. [1 ,2 ]
机构：
[1] Univ Colorado, Aurora, CO USA
[2] Natl Jewish Med Ctr, Denver, CO USA
来源：
HEPATOLOGY | 2014年 / 60卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1125
引用
收藏
页码：746A / 747A
页数：2
相关论文
共 50 条
  • [21] Non-alcoholic fatty liver disease (NAFLD)
    Rau, Monika
    Weiss, Johannes
    Geier, Andreas
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2015, 140 (14) : 1051 - +
  • [22] A novel mouse model for the study of pediatric Non-Alcoholic Fatty Liver Disease (NAFLD)
    Marin, Veronica
    Rosso, Natalia
    Dal Ben, Matteo
    Raseni, Alan
    Degrassi, Cristina
    Tiribelli, Claudio
    Gazzin, Silvia
    HEPATOLOGY, 2015, 62 : 1231A - 1231A
  • [23] AUTOPHAGY REGULATES STEATOSIS IN NON-ALCOHOLIC FATTY LIVER DISEASE IN MOUSE
    Yin, Xiao-Ming
    Zhang, Hao
    Lin, Chih-Wen
    Chen, Xi
    Chen, Xiaoyun
    HEPATOLOGY, 2011, 54 : 1158A - 1158A
  • [24] Diet containing dehulled adlay ameliorates hepatic steatosis, inflammation and insulin resistance in rats with non-alcoholic fatty liver disease
    Yeh, Wan-Ju
    Ko, Jung
    Cheng, Wei-Yi
    Yang, Hsin-Yi
    BRITISH JOURNAL OF NUTRITION, 2022, 128 (03) : 369 - 376
  • [25] Cutaneous inflammation in the DIAMOND™ mouse model of non-alcoholic fatty liver disease
    Enos, C.
    Van Voorhees, A. S.
    Marioneaux, J.
    Sanyal, A.
    Caffrey, R.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2019, 139 (05) : S84 - S84
  • [26] Decreased Hepatic Lactotransferrin Induces Hepatic Steatosis in Chronic Non-Alcoholic Fatty Liver Disease Model
    Lee, Sungmin
    Son, Beomseok
    Jeon, Jaewan
    Park, Gaeul
    Kim, Hyunwoo
    Kang, Hyunkoo
    Youn, HyeSook
    Jo, Sunmi
    Song, Jie-Young
    Youn, BuHyun
    CELLULAR PHYSIOLOGY AND BIOCHEMISTRY, 2018, 47 (06) : 2233 - 2249
  • [27] miR-101 IN STEATOSIS AND STEATOHEPATITIS OF NON-ALCOHOLIC FATTY LIVER DISEASE (NAFLD)
    Elfimova, N.
    Ommer, K.
    Schlattjan, M.
    Sowa, J. P.
    Wedemeyer, I.
    Vantler, M.
    Dienes, H. P.
    Canbay, A.
    Odenthal, M.
    JOURNAL OF HEPATOLOGY, 2013, 58 : S508 - S508
  • [28] Agai improves non-alcoholic fatty liver disease (NAFLD) induced by fructose
    de Freitas Carvalho, Mayara Medeiros
    Teixeira Reis, Larissa Lelis
    Macedo Lopes, Juliana Marcia
    Lage, Nara Nunes
    da Costa Guerra, Joyce Ferreira
    Zago, Helena Porto
    Bonomo, Larissa de Freitas
    Pereira, Renata Rebeca
    de Lima, Wanderson Geraldo
    Silva, Marcelo Eustaquio
    Pedrosa, Maria Lucia
    NUTRICION HOSPITALARIA, 2018, 35 (02) : 318 - 325
  • [29] Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis
    Thomas Klein
    Masato Fujii
    Jan Sandel
    Yuichiro Shibazaki
    Kyoko Wakamatsu
    Michael Mark
    Hiroyuki Yoneyama
    Medical Molecular Morphology, 2014, 47 : 137 - 149
  • [30] Linagliptin alleviates hepatic steatosis and inflammation in a mouse model of non-alcoholic steatohepatitis
    Klein, Thomas
    Fujii, Masato
    Sandel, Jan
    Shibazaki, Yuichiro
    Wakamatsu, Kyoko
    Mark, Michael
    Yoneyama, Hiroyuki
    MEDICAL MOLECULAR MORPHOLOGY, 2014, 47 (03) : 137 - 149
12345